Real-time vs intermittent glucose monitoring in type 2 diabetes
Part of Hormones & metabolism clinical trials.
This trial compares two types of continuous glucose monitors to see which works better for people with type 2 diabetes who use insulin. You will wear a sensor that tracks your blood sugar levels continuously or at set times, and the study will help find the best way to manage your diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 35 years or older.
- Your A1c (average blood sugar over 3 months) is above 7.0%.
- You take at least one insulin injection daily.
- Your diabetes medications have not changed in the last 3 months.
- You have been on insulin for at least 3 months with a stable dose, and your fasting blood sugar is between 70 and 130 mg/dL.
- You own a smartphone that can use near-field communication (NFC) technology.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how well periodic continuous glucose monitoring works for adults with type 2 diabetes. You may be asked to wear a sensor that tracks glucose more often than finger-stick checks, which can help improve day-to-day glucose control.
This trial is testing whether using a continuous glucose monitor (CGM) for different lengths of time helps people with type 2 diabetes understand their blood sugar patterns. You won't need to change your current diabetes medications.
This study checks whether using a continuous glucose monitor (CGM, a sensor that tracks blood sugar) is practical and helpful for people with type 2 diabetes in primary care settings. It focuses on people who may have a harder time getting diabetes support and have higher A1c levels.
This real-world study tests whether using a continuous glucose monitor (isCGM) with or without pharmacist coaching helps people with type 2 diabetes who are not on insulin improve their blood sugar control. It compares these approaches to standard blood sugar checking and looks for better HbA1c results after three months.
This trial studies how well a continuous glucose monitor (a sensor that tracks glucose) works for managing blood sugar in adults with type 1 or type 2 diabetes. You may need to wear sensors and have glucose levels adjusted during clinic visits to test safety and effectiveness.
This study gives continuous glucose monitors (CGMs) to people with type 2 diabetes who cannot afford them. It looks at whether using a CGM helps improve blood sugar control.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.